LEO Pharma is a leader in medical dermatology with a robust R&D pipeline across a wide range of therapies enabling people with severe skin diseases to access medicine and treatment.
Company Background
- Advancing the science of dermatology with a leading branded topical dermatology franchise based on decades of research and development
- Setting new standards of care for people with skin conditions with a global team of 6,000 people, serving 93 million patients in more than 130 countries
Vision & Outlook
Support LEO Pharma on its journey to strengthening its global leadership in medical dermatology
Help to expand the company's dermatology franchise and to accelerate innovation and growth
Highlights & Updates
- Committed to net zero climate target aligned with SBTi and launched ESG linked financing

SECTOR
Healthcare
REVENUES 2022
EUR 1,430 million
EMPLOYEES
5,045
OWNERSHIP
Fund X
INVESTMENT DATE
2021
HEAD OFFICE
Ballerup, Denmark